MXPA02012091A - Un metodo de tratamiento de esclerosis lateral amiotrofica con una proteina que se puede extraer de organos de mamifero. - Google Patents

Un metodo de tratamiento de esclerosis lateral amiotrofica con una proteina que se puede extraer de organos de mamifero.

Info

Publication number
MXPA02012091A
MXPA02012091A MXPA02012091A MXPA02012091A MXPA02012091A MX PA02012091 A MXPA02012091 A MX PA02012091A MX PA02012091 A MXPA02012091 A MX PA02012091A MX PA02012091 A MXPA02012091 A MX PA02012091A MX PA02012091 A MXPA02012091 A MX PA02012091A
Authority
MX
Mexico
Prior art keywords
treatment
lateral sclerosis
amyotrophic lateral
mammalian organs
protein extractable
Prior art date
Application number
MXPA02012091A
Other languages
English (en)
Inventor
Alberto Panerai
Original Assignee
Rakepoll Holding B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rakepoll Holding B V filed Critical Rakepoll Holding B V
Publication of MXPA02012091A publication Critical patent/MXPA02012091A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

Un metodo de tratamiento de pacientes afectados por esclerosis lateral amiotrofica comprende la administracion de una cantidad efectiva de una proteina 14 kDa que se puede extraer de organos de mamifero, particularmente higado de mamifero.
MXPA02012091A 2000-06-08 2001-06-04 Un metodo de tratamiento de esclerosis lateral amiotrofica con una proteina que se puede extraer de organos de mamifero. MXPA02012091A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21000300P 2000-06-08 2000-06-08
PCT/EP2001/006336 WO2001093888A2 (en) 2000-06-08 2001-06-04 A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs

Publications (1)

Publication Number Publication Date
MXPA02012091A true MXPA02012091A (es) 2004-08-19

Family

ID=22781221

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012091A MXPA02012091A (es) 2000-06-08 2001-06-04 Un metodo de tratamiento de esclerosis lateral amiotrofica con una proteina que se puede extraer de organos de mamifero.

Country Status (7)

Country Link
US (1) US6855694B2 (es)
EP (1) EP1286683A2 (es)
JP (1) JP2003535139A (es)
AU (1) AU2001278436A1 (es)
CA (1) CA2411428A1 (es)
MX (1) MXPA02012091A (es)
WO (1) WO2001093888A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070049630A1 (en) * 2005-08-24 2007-03-01 Allergan, Inc. Method of using ryanodine receptor antagonists to treat amyotrophic lateral sclerosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (it) 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.
KR20000036207A (ko) 1996-09-18 2000-06-26 스피니엘로 살바토르 자가면역 질환 치료제로서의 단백질의 용도
IT1290828B1 (it) 1997-03-25 1998-12-11 Zetesis Spa Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche

Also Published As

Publication number Publication date
JP2003535139A (ja) 2003-11-25
US20030162705A1 (en) 2003-08-28
US6855694B2 (en) 2005-02-15
EP1286683A2 (en) 2003-03-05
WO2001093888A2 (en) 2001-12-13
AU2001278436A1 (en) 2001-12-17
WO2001093888A3 (en) 2002-11-07
CA2411428A1 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
IL231675A0 (en) Concentrated protein compositions with reduced viscosity
DE59914996D1 (en) Heterocyclisch substituierte amide als calpainhemmer
MXPA03003870A (es) Terapia de combinacion que comprende agentes antidiabeticos y anticonvulsionantes.
GB0108592D0 (en) Therapeutic agents
MX9606386A (es) Agentes que afectan la hemostasis trombotica.
MXPA02001911A (es) Anticuerpos ctla-4 humanos y sus usos.
IL138476A0 (en) Method for treating pharmaceutical compositions by special use of anti-oxidant
GB9806632D0 (en) Peptide factor
TR199901104T2 (xx) Farmas�tik bile�ikler.
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
ITTO940748A0 (it) Condotto protesico particolarmente per il trattamento di patologie cardiovascolari.
BR0208727A (pt) Eritropoietina melhorando a toxicidade in vivo induzida por quimioterapia
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
RS8504A (en) Novel cyclohexil sulphones
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
GB9907571D0 (en) Compounds
PT1150703E (pt) Terapia de esclerose multipla com chaperonina 10 e beta-interferao
AU2002233220A1 (en) Medicament for preventing or treating tumors caused by human papilloma virus type 18
MXPA02012091A (es) Un metodo de tratamiento de esclerosis lateral amiotrofica con una proteina que se puede extraer de organos de mamifero.
MXPA02012089A (es) Metodo de tratamiento de la enfermedad de alzheimer con una proteina extraible de organos mamiferos.
TR200200278T2 (tr) Kalsilitik bileşimler
EA199700243A1 (ru) Производное аминотетралина для лечения сердечно-сосудистых заболеваний
MXPA01003761A (es) Agente para tratar oftalmopatia.
WO2003059387A3 (en) Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment for multiple sclerosis
MXPA02012090A (es) Un metodo de tratamiento de corea de huntington con una proteina que se puede extraer de organos de mamifero.